肥胖代谢病合并甲状腺癌外科治疗中国专家共识(2021版)

2022-01-01 中国医师协会外科医师分会肥胖和糖尿病外科医师委员会 中国实用外科杂志

肥胖症与甲状腺癌均为临床常见的内分泌与代谢疾病。肥胖与甲状腺癌的发生发展密切相关。随着肥胖患病率的逐渐增加,接受减重手术的病人越来越多。

中文标题:

肥胖代谢病合并甲状腺癌外科治疗中国专家共识(2021版)

发布日期:

2022-01-01

简要介绍:

肥胖症与甲状腺癌均为临床常见的内分泌与代谢疾病。肥胖与甲状腺癌的发生发展密切相关。随着肥胖患病率的逐渐增加,接受减重手术的病人越来越多。减重手术前甲状腺疾病筛查中经常会发现甲状腺结节,其中部分为甲状腺癌。临床上处理此类病人相对复杂。

相关资料下载:
[AttachmentFileName(sort=1, fileName=肥胖代谢病合并甲状腺癌外科治疗中国专家共识(2021版).pdf)] GetToolGuiderByIdResponse(projectId=1, id=b2c9d1c0023285bb, title=肥胖代谢病合并甲状腺癌外科治疗中国专家共识(2021版), enTitle=, guiderFrom=中国实用外科杂志, authorId=0, author=, summary=肥胖症与甲状腺癌均为临床常见的内分泌与代谢疾病。肥胖与甲状腺癌的发生发展密切相关。随着肥胖患病率的逐渐增加,接受减重手术的病人越来越多。, cover=https://img.medsci.cn/2022119/1642572788415_5579292.jpg, journalId=0, articlesId=null, associationId=1068, associationName=中国医师协会外科医师分会肥胖和糖尿病外科医师委员会, associationIntro=null, copyright=0, guiderPublishedTime=Sat Jan 01 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">肥胖症与甲状腺癌均为临床常见的内分泌与代谢疾病。肥胖与甲状腺癌的发生发展密切相关</span><span style="color: #333333;">。随着肥胖患病率的逐渐增加,接受减重手术的病人越来越多</span><span style="color: #333333;">。减重手术前甲状腺疾病筛查中经常会发现甲状腺结节,其中部分为甲状腺癌。临床上处理此类病人相对复杂。</span></p>, tagList=[TagDto(tagId=332, tagName=肥胖), TagDto(tagId=865, tagName=甲状腺癌), TagDto(tagId=1494, tagName=减重手术), TagDto(tagId=2916, tagName=代谢性疾病), TagDto(tagId=13919, tagName=肿瘤外科), TagDto(tagId=120495, tagName=内分泌外科)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=6, categoryName=内分泌, tenant=100), CategoryDto(categoryId=23, categoryName=普通外科, tenant=100), CategoryDto(categoryId=73, categoryName=头颈外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4531, appHits=104, showAppHits=0, pcHits=425, showPcHits=4427, likes=1, shares=26, comments=2, approvalStatus=1, publishedTime=Wed Jan 19 14:10:14 CST 2022, publishedTimeString=2022-01-01, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Wed Jan 19 14:16:57 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Thu Jan 04 16:35:51 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=肥胖代谢病合并甲状腺癌外科治疗中国专家共识(2021版).pdf)])
肥胖代谢病合并甲状腺癌外科治疗中国专家共识(2021版).pdf
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1231239, encodeId=41981231239a3, content=学习了,正好有肥胖症的甲状腺癌患者, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2861672661, createdName=1de15b39m16(暂无匿称), createdTime=Fri Jul 08 00:41:23 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186291, encodeId=a3fa11862914f, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Thu Jan 20 07:32:06 CST 2022, time=2022-01-20, status=1, ipAttribution=)]
    2022-07-08 1de15b39m16(暂无匿称)

    学习了,正好有肥胖症的甲状腺癌患者

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1231239, encodeId=41981231239a3, content=学习了,正好有肥胖症的甲状腺癌患者, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2861672661, createdName=1de15b39m16(暂无匿称), createdTime=Fri Jul 08 00:41:23 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186291, encodeId=a3fa11862914f, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Thu Jan 20 07:32:06 CST 2022, time=2022-01-20, status=1, ipAttribution=)]
    2022-01-20 微探

    学习学习

    0